If you've ever felt the second half of your cycle get harder over the last few years — sleep getting shallower around ovulation, anxiety pressing in the week before a period that may or may not arrive — that pattern often has a progesterone shape to it. Progesterone is one of the first dominoes to fall in perimenopause, and it falls in cycles where you don't ovulate at all. That's why "everything feels like too much" can show up years before estrogen has done anything dramatic.
Progesterone in three answers.
What it does
Progesterone is made mainly by the corpus luteum after ovulation, in the second half of the cycle. It thickens the uterine lining for a possible pregnancy, but it also has direct effects on the brain through GABA receptors — which is why progesterone tends to be quietly sedating, anti-anxiety, and sleep-supporting when it's around in good amounts.
What changes in perimenopause
Progesterone is often the FIRST hormone to start dropping in perimenopause, sometimes years before estrogen does. Cycles where you don't ovulate produce no progesterone at all, and those become more common in your forties. The estrogen-to-progesterone ratio tips, which is why a lot of perimenopause feels like 'too much' rather than 'not enough'.
Where you'll feel it
Sleep that won't deepen. Anxiety that arrives in the second half of the cycle and lifts when you bleed (or doesn't, when you skip a cycle). Heavier or more painful periods. PMS or PMDD symptoms intensifying in your forties even if they were mild before.
Noticing, assessment and follow-up
Your next steps
For yourself, or for your next appointment. These are questions and things to notice, not a diagnosis or a treatment plan.
What can I notice?
- Note bleeding dates, whether bleeding falls outside the expected schedule, sleep, mood and any grogginess after treatment. Include the dates of starting or changing the preparation and any missed doses.
Could a test help?
- A progesterone result isn't a recommended menopause diagnostic test and can't, by itself, tell you whether you need treatment. Ask what an examination or test would change in your care.
- If you have a uterus and take systemic estrogen, protection of the uterine lining is a treatment question, not something a single progesterone blood result can establish.
What happens next?
- Ask why a progestogen is being offered, which regimen fits your situation, what bleeding to expect and what to do if side effects make it difficult to take. Don't change or omit prescribed lining protection without advice.
- NICE recommends a clinical treatment review at 3 months, then annually, sooner if it isn't working or side effects develop. Ask how you'll receive any results, who'll review them and what to do before the next appointment. This isn't a schedule for routine hormone blood panels.
When shouldn't I wait?
- Ask what's expected with your particular regimen. NICE says unscheduled bleeding can be common in the first 6 months of systemic MHT, or within 3 months of changing the dose or preparation. Report bleeding beyond these windows promptly. Heavy or prolonged bleeding needs earlier assessment, whatever the timing; these windows aren't permission to ignore it.
- Seek urgent help for heavy bleeding with dizziness, fainting or breathlessness. New chest pain, sudden breathlessness or stroke-like symptoms need emergency help.
Sources for these next steps
What to say out loud.
In MHT, progesterone is usually given as oral micronized progesterone (brand names Prometrium, Utrogestan) taken at night, both to protect the uterine lining and for its sleep-onset effect. This isn't the same as the progestin in most contraceptives.
The most common confusion
Progesterone vs progestin
Progesterone is the body-identical molecule. In MHT it's prescribed as micronized progesterone (brand names Utrogestan in the UK and Europe, Prometrium in North America), usually one capsule taken at night. It protects the uterine lining when you're on estrogen, and the night-dose timing leans into its quietly sedating effect on GABA receptors.
Progestins are a whole family of synthetic molecules — medroxyprogesterone acetate (MPA, Provera), levonorgestrel (the Mirena coil), norethisterone, drospirenone, and others — engineered to mimic some of progesterone's effects, usually the lining-protecting one, without being chemically identical. They're the progestogen in most hormonal contraception, and they were the progestogen in the older MHT regimens behind the 2002 WHI breast-cancer signal. They behave differently in the body, the breast and the brain, and "progesterone" and "progestin" shouldn't be used interchangeably in your appointment.
If your prescription says "progestin" or names one of the molecules above, you're not on body-identical progesterone — and that's a fair thing to ask about, especially if sleep, mood, or PMS-like symptoms are part of why you're on it.
Pick the part you came for.
3 sections. Open one, skip the rest — nothing here depends on reading in order.
The sleep-and-mood story
Why progesterone behaves like a quiet anti-anxiety drug — when it's there
Progesterone metabolises in the brain to allopregnanolone, a positive modulator of GABA-A receptors. That's the same receptor system targeted by benzodiazepines and alcohol, which is why endogenous progesterone (especially the night-time peak) tends to be quietly sedating, anti-anxiety, and sleep-deepening when levels are good.
Read the rest
When progesterone falls — anovulatory cycles in your forties, or the wider perimenopause picture — many people describe sleep that won't deepen, anxiety that arrives in the second half of the cycle, and a sense that the same week of the month feels reliably worse. That isn't a personality drift. It's a measurable neurosteroid drop.
Progesterone vs progestin — the most-confused word in menopause care
They aren't the same molecule and they don't behave the same
Progesterone (the body's own molecule, prescribed as oral micronised progesterone — Prometrium, Utrogestan) and progestins (synthetics like medroxyprogesterone acetate, levonorgestrel, norethisterone, drospirenone) sit in the same hormone family but they're different drugs with different effects on the breast, the brain and the cardiovascular system.
Read the rest
The breast-cancer signal in the 2002 WHI study was specifically tied to MPA (a progestin), not micronised progesterone. The Mirena coil (a progestin) is the most-used progestogen half of MHT in the UK because it's convenient and very effective for heavy bleeding, but it's a synthetic. If your prescription names one of the synthetic progestins, that's a fair conversation to raise at the next review.
PMDD, PME, and the perimenopause overlap
Why the same fortnight gets worse in your forties
Some people are unusually sensitive to the brain effects of cyclic progesterone — that's the underlying biology of premenstrual dysphoric disorder (PMDD) and the related premenstrual exacerbation (PME) of existing depression, anxiety or ADHD. Perimenopause turns the dial up: cycles get longer and more variable, the luteal-phase hormone swings get bigger, and PMDD that was manageable for 20 years can become unbearable in your forties.
Read the rest
This is why the cycle-tracking question matters early in the appointment. If a clear two-week-on / two-week-off pattern is there, the conversation is partly about progesterone and partly about pathways that don't show up in the textbook chapter on menopause.
5 sources behind this pagePrimary papers and guidelines only. Each card opens the original.
Allopregnanolone, a metabolite of progesterone, is a positive modulator of GABA-A receptors and underlies the sedating and anxiolytic effects of progesterone in the brain.
Schumacher et al
The clearest mechanism paper for the 'why does Utrogestan help me sleep' question. Useful when a doctor says 'progesterone shouldn't do that'.
Read the sourceOral micronised progesterone improves sleep onset and sleep maintenance in postmenopausal women.
Why the conventional advice is to take oral progesterone at bedtime, not in the morning.
Read the sourceBody-identical micronised progesterone appears to carry a smaller breast cancer signal than synthetic progestins (particularly MPA), at least in the first 5 years of use.
Stute et al
Read the sourcePMDD is recognized as a distinct DSM-5 disorder with substantial functional impairment, often worsening in perimenopause.
Useful to bring to a doctor who treats PMDD as 'just bad PMS'.
Read the sourceThe Mirena (levonorgestrel intrauterine system) is licensed as the progestogen component of MHT and reduces menstrual blood loss by 80–95 per cent.
The reference UK guideline; widely used internationally.
Read the sourceRelated